Our Choice: Pfizer Ltd.
During 2017, Pfizer joined COMBACTE. They became both a strategic partner in the new COMBACTE-CDI project and a leader of COMBACTE-CARE as well, establishing a key role across the projects. Let’s find out what drove their decision.
Related updates
“We Take Bigger Steps Together”
COMBACTE's Last General Assembly
COMBACTE Launches Last Magazine
COMBACTE launched its last magazine at ECCMID 2023 in Copenhagen. The magazine focuses on project’s impact, and features articles and interviews with ...